| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Infections | 20 | 2026 | 74 | 5.320 |
Why?
|
| Pseudomonas aeruginosa | 23 | 2026 | 133 | 4.800 |
Why?
|
| Neutrophils | 11 | 2023 | 395 | 4.280 |
Why?
|
| Keratitis | 8 | 2023 | 19 | 2.610 |
Why?
|
| Mannose-Binding Lectin | 7 | 2009 | 10 | 1.530 |
Why?
|
| Transcriptome | 2 | 2026 | 396 | 1.430 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 5 | 2015 | 9 | 1.340 |
Why?
|
| Microbiota | 4 | 2017 | 168 | 1.340 |
Why?
|
| Conjunctiva | 2 | 2021 | 6 | 1.220 |
Why?
|
| Mice | 41 | 2026 | 11098 | 1.210 |
Why?
|
| Animals | 53 | 2026 | 21382 | 1.090 |
Why?
|
| Cornea | 6 | 2020 | 35 | 1.080 |
Why?
|
| Proteomics | 5 | 2020 | 291 | 1.040 |
Why?
|
| Complement C1q | 9 | 2010 | 17 | 1.040 |
Why?
|
| Virulence Factors | 3 | 2026 | 86 | 0.930 |
Why?
|
| Disease Models, Animal | 12 | 2026 | 2283 | 0.900 |
Why?
|
| Gene Expression Profiling | 2 | 2026 | 793 | 0.900 |
Why?
|
| Intramolecular Oxidoreductases | 3 | 2015 | 9 | 0.860 |
Why?
|
| Eye | 3 | 2020 | 59 | 0.850 |
Why?
|
| Mice, Knockout | 17 | 2023 | 2146 | 0.820 |
Why?
|
| Biofilms | 3 | 2020 | 85 | 0.810 |
Why?
|
| Mice, Inbred C57BL | 22 | 2023 | 3467 | 0.800 |
Why?
|
| Tears | 3 | 2017 | 8 | 0.800 |
Why?
|
| Immunity, Innate | 12 | 2023 | 829 | 0.760 |
Why?
|
| Eye Infections, Bacterial | 2 | 2020 | 11 | 0.750 |
Why?
|
| Homeostasis | 3 | 2019 | 377 | 0.740 |
Why?
|
| Candidiasis | 2 | 2019 | 55 | 0.710 |
Why?
|
| Cystic Fibrosis | 5 | 2017 | 127 | 0.700 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2021 | 1 | 0.690 |
Why?
|
| Nociceptors | 1 | 2021 | 13 | 0.680 |
Why?
|
| Bacteria | 3 | 2024 | 336 | 0.640 |
Why?
|
| Herpesvirus 1, Human | 2 | 2019 | 83 | 0.630 |
Why?
|
| Immunoglobulin G | 10 | 2010 | 463 | 0.610 |
Why?
|
| Keratitis, Herpetic | 1 | 2019 | 11 | 0.610 |
Why?
|
| Mass Spectrometry | 3 | 2020 | 295 | 0.610 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 115 | 0.600 |
Why?
|
| Mast Cells | 1 | 2019 | 51 | 0.580 |
Why?
|
| Proteins | 2 | 2023 | 763 | 0.550 |
Why?
|
| Extracellular Traps | 2 | 2019 | 46 | 0.550 |
Why?
|
| Mucous Membrane | 1 | 2017 | 26 | 0.530 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2017 | 22 | 0.530 |
Why?
|
| Immunoglobulin M | 5 | 2010 | 116 | 0.510 |
Why?
|
| Staphylococcus aureus | 6 | 2016 | 187 | 0.500 |
Why?
|
| Opsonin Proteins | 2 | 2014 | 32 | 0.500 |
Why?
|
| Eye Infections | 2 | 2017 | 5 | 0.480 |
Why?
|
| Epithelium, Corneal | 2 | 2013 | 9 | 0.470 |
Why?
|
| Complement System Proteins | 3 | 2014 | 110 | 0.470 |
Why?
|
| Thrombospondin 1 | 1 | 2015 | 7 | 0.460 |
Why?
|
| Lectins | 2 | 2009 | 43 | 0.450 |
Why?
|
| Protein Subunits | 6 | 2007 | 167 | 0.450 |
Why?
|
| Sjogren's Syndrome | 1 | 2015 | 25 | 0.450 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2017 | 449 | 0.430 |
Why?
|
| Complement Pathway, Classical | 2 | 2014 | 19 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 4 | 2026 | 285 | 0.420 |
Why?
|
| Sputum | 1 | 2014 | 45 | 0.420 |
Why?
|
| Staphylococcal Infections | 4 | 2017 | 135 | 0.400 |
Why?
|
| Conjunctivitis, Bacterial | 1 | 2013 | 1 | 0.390 |
Why?
|
| Caveolins | 1 | 2013 | 7 | 0.390 |
Why?
|
| Caveolin 1 | 2 | 2009 | 10 | 0.390 |
Why?
|
| NF-kappa B p50 Subunit | 3 | 2007 | 27 | 0.380 |
Why?
|
| Phagocytosis | 1 | 2014 | 268 | 0.370 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2011 | 25 | 0.350 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 4 | 2007 | 5 | 0.340 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 182 | 0.320 |
Why?
|
| Transcription Factor RelA | 2 | 2007 | 51 | 0.310 |
Why?
|
| Humans | 37 | 2026 | 64869 | 0.310 |
Why?
|
| Hepatitis B Antibodies | 1 | 2009 | 9 | 0.300 |
Why?
|
| DNA | 1 | 2014 | 851 | 0.300 |
Why?
|
| Pyrimidines | 1 | 2010 | 146 | 0.300 |
Why?
|
| Intestinal Mucosa | 2 | 2010 | 250 | 0.290 |
Why?
|
| Virulence | 3 | 2026 | 201 | 0.290 |
Why?
|
| Lipopolysaccharides | 3 | 2008 | 620 | 0.290 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 3 | 2005 | 4 | 0.280 |
Why?
|
| Herpes Simplex | 2 | 2004 | 49 | 0.260 |
Why?
|
| Autoimmunity | 1 | 2009 | 247 | 0.250 |
Why?
|
| Male | 15 | 2026 | 30935 | 0.250 |
Why?
|
| Macrophages | 3 | 2015 | 1050 | 0.240 |
Why?
|
| Complement C3a | 1 | 2005 | 7 | 0.230 |
Why?
|
| Urinary Tract Infections | 1 | 2026 | 97 | 0.220 |
Why?
|
| Female | 15 | 2026 | 33895 | 0.220 |
Why?
|
| Herpesvirus 2, Human | 1 | 2004 | 14 | 0.220 |
Why?
|
| Cytokines | 2 | 2019 | 952 | 0.210 |
Why?
|
| Iron | 1 | 2025 | 150 | 0.210 |
Why?
|
| Epithelial Cells | 3 | 2015 | 417 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 3 | 2026 | 803 | 0.200 |
Why?
|
| Shock, Septic | 1 | 2004 | 89 | 0.200 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2023 | 2 | 0.200 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 142 | 0.200 |
Why?
|
| Oxidoreductases | 1 | 2023 | 58 | 0.200 |
Why?
|
| Complement C4 | 1 | 2002 | 13 | 0.190 |
Why?
|
| Escherichia coli | 3 | 2025 | 708 | 0.190 |
Why?
|
| NF-kappa B | 1 | 2004 | 434 | 0.190 |
Why?
|
| Complement C3 | 2 | 2003 | 60 | 0.190 |
Why?
|
| Cysteine | 1 | 2023 | 107 | 0.190 |
Why?
|
| Vaccines | 1 | 2024 | 96 | 0.190 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2015 | 80 | 0.190 |
Why?
|
| Protein Binding | 5 | 2010 | 1640 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2017 | 261 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 3 | 2021 | 414 | 0.180 |
Why?
|
| Bacterial Proteins | 2 | 2025 | 744 | 0.180 |
Why?
|
| Neutrophil Infiltration | 2 | 2019 | 64 | 0.180 |
Why?
|
| Immunologic Factors | 2 | 2019 | 108 | 0.170 |
Why?
|
| Streptococcus | 1 | 2021 | 19 | 0.170 |
Why?
|
| Mannans | 1 | 2001 | 22 | 0.170 |
Why?
|
| Intestines | 2 | 2015 | 178 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2019 | 3146 | 0.160 |
Why?
|
| Immunoproteins | 1 | 2019 | 2 | 0.150 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 21 | 0.150 |
Why?
|
| Binding Sites | 4 | 2010 | 920 | 0.150 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 240 | 0.150 |
Why?
|
| Meningoencephalitis | 1 | 2019 | 9 | 0.150 |
Why?
|
| Half-Life | 1 | 2019 | 81 | 0.150 |
Why?
|
| Cell Communication | 1 | 2019 | 134 | 0.150 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2019 | 70 | 0.150 |
Why?
|
| Proteome | 1 | 2019 | 151 | 0.140 |
Why?
|
| Antifungal Agents | 1 | 2019 | 130 | 0.140 |
Why?
|
| Species Specificity | 1 | 2019 | 340 | 0.140 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 80 | 0.140 |
Why?
|
| Glatiramer Acetate | 1 | 2017 | 8 | 0.140 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2017 | 42 | 0.130 |
Why?
|
| Bacteroides | 1 | 2017 | 10 | 0.130 |
Why?
|
| Corynebacterium Infections | 1 | 2017 | 1 | 0.130 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 31 | 0.130 |
Why?
|
| Lymphoid Tissue | 1 | 2017 | 55 | 0.130 |
Why?
|
| Corynebacterium | 1 | 2017 | 4 | 0.130 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 56 | 0.130 |
Why?
|
| Burkholderia Infections | 1 | 2017 | 3 | 0.130 |
Why?
|
| Apoptosis | 3 | 2009 | 1094 | 0.130 |
Why?
|
| Arginine | 3 | 2008 | 136 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1289 | 0.130 |
Why?
|
| Symbiosis | 1 | 2017 | 37 | 0.130 |
Why?
|
| Flagellin | 1 | 2017 | 14 | 0.130 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 54 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 105 | 0.130 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 198 | 0.130 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 95 | 0.130 |
Why?
|
| Stem Cells | 1 | 2019 | 275 | 0.130 |
Why?
|
| Candida albicans | 1 | 2017 | 75 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 135 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2019 | 636 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 211 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2017 | 99 | 0.120 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 102 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 235 | 0.120 |
Why?
|
| Complement Activation | 3 | 2009 | 50 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 605 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2001 | 719 | 0.120 |
Why?
|
| Flagella | 1 | 2017 | 144 | 0.120 |
Why?
|
| Microglia | 1 | 2019 | 250 | 0.120 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 711 | 0.120 |
Why?
|
| Radiation Chimera | 3 | 2004 | 61 | 0.120 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2015 | 11 | 0.120 |
Why?
|
| Spleen | 3 | 2013 | 473 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2015 | 8 | 0.110 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2013 | 2 | 0.110 |
Why?
|
| Membrane Microdomains | 2 | 2013 | 52 | 0.110 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 127 | 0.110 |
Why?
|
| Lysine | 2 | 2008 | 94 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2188 | 0.100 |
Why?
|
| HL-60 Cells | 1 | 2014 | 17 | 0.100 |
Why?
|
| Kidney | 2 | 2007 | 451 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2014 | 876 | 0.100 |
Why?
|
| Serine Endopeptidases | 2 | 2004 | 121 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 37 | 0.100 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 80 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 102 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 247 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2013 | 96 | 0.090 |
Why?
|
| Ligands | 3 | 2008 | 415 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 1006 | 0.090 |
Why?
|
| Lung | 4 | 2017 | 966 | 0.090 |
Why?
|
| Computational Biology | 3 | 2024 | 366 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 181 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2026 | 208 | 0.090 |
Why?
|
| Histidine | 2 | 2004 | 36 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1569 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 869 | 0.080 |
Why?
|
| Inflammation | 2 | 2015 | 1191 | 0.080 |
Why?
|
| Models, Molecular | 3 | 2010 | 1159 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2024 | 1591 | 0.080 |
Why?
|
| Carrier State | 1 | 2010 | 20 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2008 | 251 | 0.080 |
Why?
|
| Antibodies, Bacterial | 1 | 2010 | 182 | 0.080 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2009 | 18 | 0.080 |
Why?
|
| Immunization | 1 | 2009 | 136 | 0.070 |
Why?
|
| Fungi | 1 | 2009 | 61 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2008 | 789 | 0.070 |
Why?
|
| Endocytosis | 1 | 2009 | 153 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2006 | 168 | 0.070 |
Why?
|
| Viruses | 1 | 2009 | 81 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2009 | 666 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 84 | 0.070 |
Why?
|
| Epitopes | 1 | 2008 | 291 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2007 | 32 | 0.070 |
Why?
|
| Streptozocin | 1 | 2007 | 23 | 0.070 |
Why?
|
| Indians, South American | 1 | 2007 | 2 | 0.060 |
Why?
|
| Mutation | 2 | 2017 | 2657 | 0.060 |
Why?
|
| Multilocus Sequence Typing | 1 | 2026 | 6 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 980 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2006 | 2 | 0.060 |
Why?
|
| Alabama | 1 | 2026 | 85 | 0.060 |
Why?
|
| Helicobacter hepaticus | 1 | 2006 | 3 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 206 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 159 | 0.060 |
Why?
|
| Calcium | 2 | 2008 | 579 | 0.060 |
Why?
|
| Cell Line | 3 | 2017 | 2033 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2026 | 84 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1631 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2005 | 74 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2026 | 59 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2006 | 127 | 0.060 |
Why?
|
| Kidney Tubules | 1 | 2005 | 23 | 0.060 |
Why?
|
| Herpes Genitalis | 1 | 2004 | 3 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 57 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2004 | 46 | 0.050 |
Why?
|
| Edema | 1 | 2004 | 42 | 0.050 |
Why?
|
| Point Mutation | 4 | 2006 | 165 | 0.050 |
Why?
|
| Necrosis | 1 | 2005 | 148 | 0.050 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2004 | 42 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2004 | 127 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 192 | 0.050 |
Why?
|
| Viral Load | 1 | 2004 | 230 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 373 | 0.050 |
Why?
|
| Colon | 1 | 2004 | 147 | 0.050 |
Why?
|
| Pseudomonas | 1 | 2023 | 8 | 0.050 |
Why?
|
| Galectins | 1 | 2023 | 9 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2004 | 222 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2003 | 98 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2002 | 3 | 0.050 |
Why?
|
| Haptens | 1 | 2002 | 13 | 0.050 |
Why?
|
| Hemocyanins | 1 | 2002 | 24 | 0.050 |
Why?
|
| Nitrophenols | 1 | 2002 | 3 | 0.050 |
Why?
|
| Recurrence | 1 | 2004 | 655 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 271 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2023 | 112 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2002 | 74 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2002 | 110 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 145 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 137 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2025 | 275 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 302 | 0.050 |
Why?
|
| Phenotype | 1 | 2026 | 1232 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 393 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 630 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 326 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 274 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 351 | 0.040 |
Why?
|
| Collectins | 1 | 2001 | 4 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 261 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 733 | 0.040 |
Why?
|
| Software | 1 | 2024 | 394 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2006 | 461 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2020 | 61 | 0.040 |
Why?
|
| Liver | 1 | 2004 | 867 | 0.040 |
Why?
|
| Adult | 3 | 2026 | 17277 | 0.040 |
Why?
|
| Aged | 2 | 2026 | 14867 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 168 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 347 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2019 | 95 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1998 | 86 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2017 | 6 | 0.030 |
Why?
|
| Middle Aged | 2 | 2026 | 18161 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 364 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 338 | 0.030 |
Why?
|
| Burkholderia | 1 | 2017 | 2 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2017 | 17 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 66 | 0.030 |
Why?
|
| Epidemics | 1 | 2017 | 27 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 69 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 502 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 26 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2016 | 48 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2016 | 37 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 493 | 0.030 |
Why?
|
| Brain | 1 | 2004 | 1598 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 334 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 151 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 358 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 61 | 0.030 |
Why?
|
| TRPP Cation Channels | 1 | 2015 | 26 | 0.030 |
Why?
|
| Interleukins | 1 | 2015 | 86 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 125 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1982 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 677 | 0.030 |
Why?
|
| Rats | 1 | 1998 | 2054 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 130 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2013 | 67 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Bacteremia | 1 | 2010 | 92 | 0.020 |
Why?
|
| Neutropenia | 1 | 2010 | 67 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 200 | 0.020 |
Why?
|
| Colforsin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 2009 | 11 | 0.020 |
Why?
|
| Chlorides | 1 | 2009 | 32 | 0.020 |
Why?
|
| Cross Infection | 1 | 2010 | 165 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 572 | 0.020 |
Why?
|
| Triterpenes | 1 | 2008 | 7 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2009 | 86 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 2008 | 27 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2008 | 65 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 2008 | 85 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2007 | 4 | 0.020 |
Why?
|
| Greenland | 1 | 2007 | 2 | 0.020 |
Why?
|
| Hong Kong | 1 | 2007 | 4 | 0.020 |
Why?
|
| Zambia | 1 | 2007 | 19 | 0.020 |
Why?
|
| Albumins | 1 | 2007 | 43 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 173 | 0.020 |
Why?
|
| Creatinine | 1 | 2007 | 135 | 0.020 |
Why?
|
| Brazil | 1 | 2007 | 102 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 122 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2006 | 71 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 300 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 759 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 92 | 0.020 |
Why?
|
| Butadienes | 1 | 2006 | 14 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2006 | 18 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2006 | 90 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 205 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 56 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2007 | 190 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2005 | 25 | 0.010 |
Why?
|
| Nitriles | 1 | 2006 | 84 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 386 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 418 | 0.010 |
Why?
|
| Static Electricity | 1 | 2005 | 170 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 392 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 164 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 673 | 0.010 |
Why?
|
| Protein Folding | 1 | 2006 | 269 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 281 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 198 | 0.010 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Genome | 1 | 2006 | 285 | 0.010 |
Why?
|
| Hemolysis | 1 | 2004 | 41 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 347 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 50 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 2003 | 12 | 0.010 |
Why?
|
| CD11b Antigen | 1 | 2003 | 19 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2003 | 35 | 0.010 |
Why?
|
| Sheep | 1 | 2004 | 189 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 197 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2004 | 146 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 105 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 2003 | 81 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2003 | 231 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 76 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2003 | 316 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 538 | 0.010 |
Why?
|